China Pharma (CPHI) Competitors $0.28 -0.01 (-4.24%) As of 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock CPHI vs. FNCH, JATT, CVM, CYTH, LIAN, CMMB, NAII, LSTA, NNVC, and BIVIShould you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include Finch Therapeutics Group (FNCH), JATT Acquisition (JATT), CEL-SCI (CVM), Cyclo Therapeutics (CYTH), LianBio (LIAN), Chemomab Therapeutics (CMMB), Natural Alternatives International (NAII), Lisata Therapeutics (LSTA), NanoViricides (NNVC), and BioVie (BIVI). These companies are all part of the "pharmaceutical products" industry. China Pharma vs. Finch Therapeutics Group JATT Acquisition CEL-SCI Cyclo Therapeutics LianBio Chemomab Therapeutics Natural Alternatives International Lisata Therapeutics NanoViricides BioVie China Pharma (NYSE:CPHI) and Finch Therapeutics Group (NASDAQ:FNCH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation. Does the MarketBeat Community favor CPHI or FNCH? Finch Therapeutics Group received 10 more outperform votes than China Pharma when rated by MarketBeat users. Likewise, 52.63% of users gave Finch Therapeutics Group an outperform vote while only 0.00% of users gave China Pharma an outperform vote. CompanyUnderperformOutperformChina PharmaOutperform VotesNo VotesUnderperform Votes88100.00% Finch Therapeutics GroupOutperform Votes1052.63% Underperform Votes947.37% Is CPHI or FNCH more profitable? Finch Therapeutics Group has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. China Pharma's return on equity of -63.93% beat Finch Therapeutics Group's return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% Finch Therapeutics Group N/A -69.14%-26.92% Which has higher earnings & valuation, CPHI or FNCH? China Pharma has higher revenue and earnings than Finch Therapeutics Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$5.54M0.97-$3.08MN/AN/AFinch Therapeutics Group$110K205.23-$74.75M-$8.82-1.59 Does the media prefer CPHI or FNCH? In the previous week, China Pharma had 1 more articles in the media than Finch Therapeutics Group. MarketBeat recorded 1 mentions for China Pharma and 0 mentions for Finch Therapeutics Group. China Pharma's average media sentiment score of 0.00 equaled Finch Therapeutics Group'saverage media sentiment score. Company Overall Sentiment China Pharma Neutral Finch Therapeutics Group Neutral Do insiders & institutionals hold more shares of CPHI or FNCH? 21.8% of Finch Therapeutics Group shares are owned by institutional investors. 17.3% of China Pharma shares are owned by insiders. Comparatively, 44.9% of Finch Therapeutics Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, CPHI or FNCH? China Pharma has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, Finch Therapeutics Group has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500. SummaryFinch Therapeutics Group beats China Pharma on 8 of the 12 factors compared between the two stocks. Remove Ads Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPHI vs. The Competition Export to ExcelMetricChina PharmaPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$5.35M$6.93B$5.63B$19.33BDividend YieldN/A2.73%4.57%3.75%P/E RatioN/A7.1623.1232.92Price / Sales0.97221.41388.1726.59Price / CashN/A65.6738.1617.54Price / Book0.406.386.884.52Net Income-$3.08M$142.12M$3.20B$1.02B7 Day Performance17.90%-4.83%-2.86%-1.37%1 Month Performance32.44%-7.22%1.72%-4.11%1 Year Performance-25.11%-8.75%9.77%3.29% China Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPHIChina PharmaN/A$0.28-4.2%N/A-23.4%$5.35M$5.54M0.00250FNCHFinch Therapeutics GroupN/A$13.75+0.7%N/A+403.5%$22.08M$110,000.00-1.56190Gap UpJATTJATT AcquisitionN/A$1.28+18.5%N/A-35.8%$22.08MN/A0.003High Trading VolumeCVMCEL-SCIN/A$0.28-6.5%N/A-87.4%$21.94MN/A-0.5943High Trading VolumeCYTHCyclo Therapeutics2.8683 of 5 stars$0.66-5.6%$0.95+43.7%N/A$21.76M$870,725.00-0.739Upcoming EarningsShort Interest ↓LIANLianBioN/A$0.20flatN/A-38.0%$21.61MN/A-0.25110Gap DownCMMBChemomab Therapeutics3.6841 of 5 stars$1.50+6.4%$9.00+500.0%+42.9%$21.54MN/A-1.5020Short Interest ↓News CoverageNAIINatural Alternatives International0.7808 of 5 stars$3.47-0.9%N/A-43.3%$21.51M$121.85M-2.69290Analyst ForecastShort Interest ↑News CoverageLSTALisata Therapeutics3.0607 of 5 stars$2.38-0.4%$15.00+530.3%-27.7%$20.52M$1M-0.9530Short Interest ↓Gap DownNNVCNanoViricidesN/A$1.31+6.5%N/A+7.1%$20.49MN/A-1.8220News CoverageBIVIBioVie2.8499 of 5 stars$1.10+1.9%$3.00+172.7%+102.4%$20.30MN/A-0.1110Short Interest ↓News CoveragePositive News Remove Ads Related Companies and Tools Related Companies Finch Therapeutics Group Competitors JATT Acquisition Competitors CEL-SCI Competitors Cyclo Therapeutics Competitors LianBio Competitors Chemomab Therapeutics Competitors Natural Alternatives International Competitors Lisata Therapeutics Competitors NanoViricides Competitors BioVie Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CPHI) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CPHI Stock Free CPHI Stock Alerts